TY - JOUR
T1 - Molecular Transducers of Physical Activity Consortium (MoTrPAC)
T2 - human studies design and protocol
AU - MoTrPAC Study Group
AU - Jakicic, John M.
AU - Kohrt, Wendy M.
AU - Houmard, Joseph A.
AU - Miller, Michael E.
AU - Radom-Aizik, Shlomit
AU - Rasmussen, Blake B.
AU - Ravussin, Eric
AU - Serra, Monica
AU - Stowe, Cynthia L.
AU - Trappe, Scott
AU - Abouassi, Hiba
AU - Adkins, Joshua N.
AU - Alekel, D. Lee
AU - Ashley, Euan
AU - Bamman, Marcas M.
AU - Bergman, Bryan C.
AU - Bessesen, Daniel H.
AU - Broskey, Nicholas T.
AU - Buford, Thomas W.
AU - Burant, Charles F.
AU - Chen, Haiying
AU - Christle, Jeffrey W.
AU - Clish, Clary B.
AU - Coen, Paul M.
AU - Collier, David
AU - Collins, Katherine A.
AU - Cooper, Daniel M.
AU - Cortes, Tiffany
AU - Cutter, Gary R.
AU - Dubis, Gabriel
AU - Fernández, Facundo M.
AU - Firnhaber, Jonathon
AU - Forman, Daniel E.
AU - Gaul, David A.
AU - Gay, Nicole
AU - Gerszten, Robert E.
AU - Goodpaster, Bret H.
AU - Gritsenko, Marina A.
AU - Haddad, Fadia
AU - Huffman, Kim M.
AU - Ilkayeva, Olga
AU - Jankowski, Catherine M.
AU - Jin, Christopher
AU - Johannsen, Neil M.
AU - Johnson, Johanna
AU - Kelly, Leslie
AU - Kershaw, Erin
AU - Kraus, William E.
AU - Musi, Nicolas
AU - Volpi, Elena
N1 - Publisher Copyright:
© 2024 American Physiological Society. All rights reserved.
PY - 2024/9
Y1 - 2024/9
N2 - Physical activity, including structured exercise, is associated with favorable health-related chronic disease outcomes. Although there is evidence of various molecular pathways that affect these responses, a comprehensive molecular map of these molecular responses to exercise has not been developed. The Molecular Transducers of Physical Activity Consortium (MoTrPAC) is a multicenter study designed to isolate the effects of structured exercise training on the molecular mechanisms underlying the health benefits of exercise and physical activity. MoTrPAC contains both a preclinical and human component. The details of the human studies component of MoTrPAC that include the design and methods are presented here. The human studies contain both an adult and pediatric component. In the adult component, sedentary participants are randomized to 12 wk of Control, Endurance Exercise Training, or Resistance Exercise Training with outcomes measures completed before and following the 12 wk. The adult component also includes recruitment of highly active endurance-trained or resistance-trained participants who only complete measures once. A similar design is used for the pediatric component; however, only endurance exercise is examined. Phenotyping measures include weight, body composition, vital signs, cardiorespiratory fitness, muscular strength, physical activity and diet, and other questionnaires. Participants also complete an acute rest period (adults only) or exercise session (adults, pediatrics) with collection of biospecimens (blood only for pediatrics) to allow for examination of the molecular responses. The design and methods of MoTrPAC may inform other studies. Moreover, MoTrPAC will provide a repository of data that can be used broadly across the scientific community. NEW & NOTEWORTHY The Molecular Transducers of Physical Activity Consortium (MoTrPAC) will be the first large trial to isolate the effects of structured exercise training on the molecular mechanisms underlying the health benefits of exercise and physical activity. By generating a compendium of the molecular responses to exercise, MoTrPAC will lay the foundation for a new era of biomedical research on Precision Exercise Medicine. Presented here is the design, protocols, and procedures for the MoTrPAC human studies.
AB - Physical activity, including structured exercise, is associated with favorable health-related chronic disease outcomes. Although there is evidence of various molecular pathways that affect these responses, a comprehensive molecular map of these molecular responses to exercise has not been developed. The Molecular Transducers of Physical Activity Consortium (MoTrPAC) is a multicenter study designed to isolate the effects of structured exercise training on the molecular mechanisms underlying the health benefits of exercise and physical activity. MoTrPAC contains both a preclinical and human component. The details of the human studies component of MoTrPAC that include the design and methods are presented here. The human studies contain both an adult and pediatric component. In the adult component, sedentary participants are randomized to 12 wk of Control, Endurance Exercise Training, or Resistance Exercise Training with outcomes measures completed before and following the 12 wk. The adult component also includes recruitment of highly active endurance-trained or resistance-trained participants who only complete measures once. A similar design is used for the pediatric component; however, only endurance exercise is examined. Phenotyping measures include weight, body composition, vital signs, cardiorespiratory fitness, muscular strength, physical activity and diet, and other questionnaires. Participants also complete an acute rest period (adults only) or exercise session (adults, pediatrics) with collection of biospecimens (blood only for pediatrics) to allow for examination of the molecular responses. The design and methods of MoTrPAC may inform other studies. Moreover, MoTrPAC will provide a repository of data that can be used broadly across the scientific community. NEW & NOTEWORTHY The Molecular Transducers of Physical Activity Consortium (MoTrPAC) will be the first large trial to isolate the effects of structured exercise training on the molecular mechanisms underlying the health benefits of exercise and physical activity. By generating a compendium of the molecular responses to exercise, MoTrPAC will lay the foundation for a new era of biomedical research on Precision Exercise Medicine. Presented here is the design, protocols, and procedures for the MoTrPAC human studies.
KW - adipose tissue
KW - biospecimens
KW - molecular transducers
KW - physical activity
KW - skeletal muscle
UR - http://www.scopus.com/inward/record.url?scp=85203302114&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85203302114&partnerID=8YFLogxK
U2 - 10.1152/japplphysiol.00102.2024
DO - 10.1152/japplphysiol.00102.2024
M3 - Article
C2 - 38634503
AN - SCOPUS:85203302114
SN - 8750-7587
VL - 137
SP - 473
EP - 493
JO - Journal of applied physiology
JF - Journal of applied physiology
IS - 3
ER -